SI21370A - Nove soli antikonvulzantnih derivatov - Google Patents

Nove soli antikonvulzantnih derivatov Download PDF

Info

Publication number
SI21370A
SI21370A SI200220021A SI200220021A SI21370A SI 21370 A SI21370 A SI 21370A SI 200220021 A SI200220021 A SI 200220021A SI 200220021 A SI200220021 A SI 200220021A SI 21370 A SI21370 A SI 21370A
Authority
SI
Slovenia
Prior art keywords
common
salt
formula
compound
topiramate
Prior art date
Application number
SI200220021A
Other languages
English (en)
Slovenian (sl)
Inventor
Ahmed Abdel-Magid
Cynthia Maryanoff
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23174444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI21370(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of SI21370A publication Critical patent/SI21370A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
SI200220021A 2001-07-09 2002-07-03 Nove soli antikonvulzantnih derivatov SI21370A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30396201P 2001-07-09 2001-07-09
PCT/US2002/021016 WO2003006467A1 (en) 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts

Publications (1)

Publication Number Publication Date
SI21370A true SI21370A (sl) 2004-06-30

Family

ID=23174444

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200220021A SI21370A (sl) 2001-07-09 2002-07-03 Nove soli antikonvulzantnih derivatov

Country Status (27)

Country Link
US (2) US7098188B2 (xx)
EP (1) EP1414824B1 (xx)
JP (1) JP2005502629A (xx)
KR (1) KR20040013127A (xx)
CN (1) CN1288159C (xx)
AR (1) AR036137A1 (xx)
AT (1) ATE361304T1 (xx)
AU (1) AU2002346042B2 (xx)
BR (1) BR0211063A (xx)
CA (1) CA2452612A1 (xx)
DE (1) DE60219922T2 (xx)
DK (1) DK1414824T3 (xx)
ES (1) ES2284884T3 (xx)
HK (1) HK1064094A1 (xx)
HR (1) HRP20040017A2 (xx)
HU (1) HUP0401080A2 (xx)
IL (2) IL159698A0 (xx)
MX (1) MXPA04000232A (xx)
NO (1) NO20040066L (xx)
NZ (1) NZ530507A (xx)
PL (1) PL367635A1 (xx)
PT (1) PT1414824E (xx)
RU (1) RU2320665C2 (xx)
SI (1) SI21370A (xx)
UA (1) UA78211C2 (xx)
WO (1) WO2003006467A1 (xx)
ZA (1) ZA200400970B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041650B2 (en) 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
CA2465952A1 (en) * 2001-11-06 2003-05-15 Ortho-Mcneil Pharmaceutical, Inc. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US6559293B1 (en) * 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
JP4906233B2 (ja) 2002-03-01 2012-03-28 ユニバーシティー オブ サウス フロリダ 少なくとも１種の有効薬剤成分を含有する多構成要素固相
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
MXPA05000232A (es) * 2002-06-21 2005-06-17 Transform Pharmaceuticals Inc Composiciones farmaceuticas con disolucion mejorada.
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9489372B2 (en) * 2013-03-15 2016-11-08 Apple Inc. Web-based spell checker
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
TWI826531B (zh) 2018-09-21 2023-12-21 南韓商愛思開生物製藥股份有限公司 具有㗁二唑之化合物及包含該化合物之醫藥組合物
US20210169844A1 (en) 2019-12-10 2021-06-10 Tulex Pharmaceuticals Inc. Compositions and methods for treating epilepsy, seizures and other conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
BR0008477A (pt) * 1999-02-24 2002-01-22 Univ Cincinnati Método para tratar um distúrbio de controle do impulso
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
WO2003006467A1 (en) 2003-01-23
UA78211C2 (en) 2007-03-15
ATE361304T1 (de) 2007-05-15
ES2284884T3 (es) 2007-11-16
NO20040066L (no) 2004-03-01
NZ530507A (en) 2007-01-26
CA2452612A1 (en) 2003-01-23
IL159698A (en) 2009-09-22
CN1288159C (zh) 2006-12-06
US7098188B2 (en) 2006-08-29
AU2002346042B8 (en) 2003-01-29
DE60219922T2 (de) 2008-01-17
JP2005502629A (ja) 2005-01-27
HK1064094A1 (en) 2005-01-21
PL367635A1 (en) 2005-03-07
IL159698A0 (en) 2004-06-20
CN1551882A (zh) 2004-12-01
RU2320665C2 (ru) 2008-03-27
HRP20040017A2 (en) 2004-10-31
RU2004100274A (ru) 2005-06-20
PT1414824E (pt) 2007-06-27
BR0211063A (pt) 2004-07-20
AU2002346042B2 (en) 2007-10-18
DE60219922D1 (de) 2007-06-14
DK1414824T3 (da) 2007-07-16
HUP0401080A2 (hu) 2004-09-28
KR20040013127A (ko) 2004-02-11
ZA200400970B (en) 2005-02-07
EP1414824B1 (en) 2007-05-02
MXPA04000232A (es) 2005-03-07
US20030069190A1 (en) 2003-04-10
AR036137A1 (es) 2004-08-11
US20060105966A1 (en) 2006-05-18
EP1414824A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
US20060105966A1 (en) Novel anticonvulsant derivative salts
RU2328502C2 (ru) Новые замещенные сульфаматные противосудорожные производные
RU2197481C2 (ru) Производные хинолина
AU2002346042A1 (en) Novel anticonvulsant derivative salts
CZ295618B6 (cs) Pyrazinové deriváty, způsob výroby a farmaceutický prostředek
BRPI0920356B1 (pt) Processo para a preparação de compostos úteis como inibidores de sglt
TW200927105A (en) Process for the preparation of compounds useful as inhibitors of SGLT
BR112012008939B1 (pt) Processo para a preparação de compostos úteis como inibidores de sglt2
JP2012502928A (ja) Ｃｒｔｈ２受容体アンタゴニストとしてのアザインドール誘導体
NO141756B (no) Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater
US7041650B2 (en) Anticonvulsant derivative salts
ZA200402626B (en) New hydroxyalkylindolocarbazole compounds, a process for their preparation and pharmaceutical compositions containing them
US10844018B2 (en) Pyridoxine derivative for treatment of epilepsy
KR100807894B1 (ko) 포스핀산 유도체

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20100311